Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension (fimasartan)

This study has been completed.
Bucheon St. Mary's Hospital
Konyang University Hospital
Korea University Anam Hospital
National Health Insurance Service Ilsan Hospital
Daegu Fatima Hospital
Dong-A University
Soon Chun Hyang University
Asan Medical Center
Gangnam Severance Hospital
Severance Hospital
Ulsan University Hospital
Kangbuk Samsung Hospital
Sejong General Hospital
Ewha Womans University Mokdong Hospital
Jeju National University Hospital
Hallym University Medical Center
Hanyang University
Information provided by (Responsible Party):
Boryung Pharmaceutical Co., Ltd Identifier:
First received: August 20, 2012
Last updated: June 30, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):